APA (7th ed.) Citation

Carter, C., Houser, K. V., Yamshchikov, G. V., Bellamy, A. R., May, J., Enama, M. E., . . . Ledgerwood, J. E. (2019). Safety and immunogenicity of investigational seasonal influenza hemagglutinin DNA vaccine followed by trivalent inactivated vaccine administered intradermally or intramuscularly in healthy adults: An open-label randomized phase 1 clinical trial. PloS one, 14(9), e0222178. https://doi.org/10.1371/journal.pone.0222178

Chicago Style (17th ed.) Citation

Carter, Cristina, et al. "Safety and Immunogenicity of Investigational Seasonal Influenza Hemagglutinin DNA Vaccine Followed by Trivalent Inactivated Vaccine Administered Intradermally or Intramuscularly in Healthy Adults: An Open-label Randomized Phase 1 Clinical Trial." PloS One 14, no. 9 (2019): e0222178. https://doi.org/10.1371/journal.pone.0222178.

MLA (9th ed.) Citation

Carter, Cristina, et al. "Safety and Immunogenicity of Investigational Seasonal Influenza Hemagglutinin DNA Vaccine Followed by Trivalent Inactivated Vaccine Administered Intradermally or Intramuscularly in Healthy Adults: An Open-label Randomized Phase 1 Clinical Trial." PloS One, vol. 14, no. 9, 2019, p. e0222178, https://doi.org/10.1371/journal.pone.0222178.